1.46
Finanzdaten der Biorestorative Therapies Inc-Aktie (BRTX)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
18.21%
0.0232
|
0.0196 | 0.0118 | 0.3033 | 0.025 |
| Cost Of Revenue |
351.41%
0.00739
|
0.00164 | 0.0106 | 0.00873 | 0.00291 |
| Gross Profit |
12.13%
0.0158
|
0.018 | 0.00123 | 0.2946 | 0.0221 |
| Operating Expenses |
11.49%
3.4015
|
3.8433 | 3.7102 | 3.5999 | 4.8296 |
| Depreciation and Amortization |
0.84%
0.0524
|
0.0528 | 0.0526 | 0.0527 | 0.0518 |
| Operating Income/Loss |
11.49%
-3.3857
|
-3.8253 | -3.709 | -3.3053 | -4.8075 |
| Nonoperating Income/Loss |
99.35%
1.2313
|
0.6177 | 0.6707 | 0.649 | -0.5323 |
| Net Income/Loss |
32.84%
-2.1544
|
-3.2076 | -3.0383 | -2.6563 | -5.3398 |
| Basic Average Shares |
17.73
|
- | 9.1162 | 8.7404 | 8.3571 |
| Diluted Average Shares |
17.73
|
- | 9.1162 | 8.7404 | 8.3571 |
| Basic Earnings Per Share |
-0.12
|
- | -0.33 | -0.30 | -0.64 |
| Diluted Earnings Per Share |
-0.12
|
- | -0.33 | -0.30 | -0.64 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):